AngioDynamics, a Latham-based maker of medical devices, saw net sales and net income rise in the most recent fiscal year.
Net sales rose 4 percent from $342 million in fiscal year 2013 to $354.5 million in fiscal year 2014. Net income was $3.1 million, or 9 cents a share, in the last fiscal year, compared to a net loss of $600,000, or 2 cents per share, a year prior.
Earnings before interest, taxes, depreciation and amortization were $38.3 million, or $1.08 per share, compared to $32.3 million, or 91 cents per share, a year ago.
“As we progress through fiscal year 2015 we will continue to implement our operational excellence plan and expect earnings growth to outpace sales increases,” said President and CEO Joseph M. DeVivo in a news release.
AngioDynamics expects revenue to range from $83 million to $86 million in the first quarter of the 2015 fiscal year.